Most Patients With Neovascular Eye Disease Prefer Anti-VEGF Implant
(MedPage Today) -- Reduced treatment burden for neovascular age-related macular degeneration met with overwhelming approval in an analysis of patient-reported outcomes (PROs) from a randomized trial.
After 40 weeks of follow-up, about two-thirds...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Primary Care